SEC Form 4 · accession 0001140361-16-059664
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Biodefense Divison
Period of report
Mar 30, 2016
Accepted (ET)
Mar 31, 2016 · 1:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 30, 2016 | M | 3,467 | $15.91 | A | 40,972 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $15.91 | Mar 30, 2016 | M | 3,467 | A | — | Mar 8, 2017 | Common Stock | 3,467 | 0 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on March 9, 2010.
- F2The option vested in three equal installments in March 2011, 2012 and 2013.